Jagotec

Jagotec is a specialized drug delivery company that operates as a subsidiary of Skyepharma (now part of Vectura). The company is primarily recognized for developing and licensing the Geomatrix technology, a sophisticated multi-layer tablet platform designed for controlled-release oral drug delivery. This technology allows for customized release profiles, such as constant, delayed, or pulsed release, by utilizing barrier layers to control the surface area of the drug core. Jagotec's innovations have been integrated into several high-profile commercial products, including Paxil CR and Requip XL, through long-standing partnerships with major pharmaceutical companies like GSK and Roche. Today, it continues to manage a portfolio of intellectual property related to oral formulation and modified-release technologies.